Connection

Narendra Vyavahare to Heart Valve Prosthesis

Back to Details
This is a "connection" page, showing publications Narendra Vyavahare has written about Heart Valve Prosthesis.
Narendra Vyavahare
Connection Strength
5.035
Heart Valve Prosthesis
  1. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties. J Cardiovasc Transl Res. 2017 Apr; 10(2):194-205.
    View in: PubMed
    Score: 0.491
  2. A novel crosslinking method for improved tear resistance and biocompatibility of tissue based biomaterials. Biomaterials. 2015 Oct; 66:83-91.
    View in: PubMed
    Score: 0.440
  3. Neomycin and pentagalloyl glucose enhanced cross-linking for elastin and glycosaminoglycans preservation in bioprosthetic heart valves. J Biomater Appl. 2014 Jan; 28(5):757-66.
    View in: PubMed
    Score: 0.395
  4. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves. J Biomater Appl. 2013 May; 27(8):948-60.
    View in: PubMed
    Score: 0.344
  5. Porcine vena cava as an alternative to bovine pericardium in bioprosthetic percutaneous heart valves. Biomaterials. 2012 Jan; 33(1):1-8.
    View in: PubMed
    Score: 0.339
  6. Neomycin enhances extracellular matrix stability of glutaraldehyde crosslinked bioprosthetic heart valves. J Biomed Mater Res B Appl Biomater. 2011 Nov; 99(2):217-29.
    View in: PubMed
    Score: 0.332
  7. Neomycin fixation followed by ethanol pretreatment leads to reduced buckling and inhibition of calcification in bioprosthetic valves. J Biomed Mater Res B Appl Biomater. 2010 Jan; 92(1):168-77.
    View in: PubMed
    Score: 0.300
  8. Neomycin binding preserves extracellular matrix in bioprosthetic heart valves during in vitro cyclic fatigue and storage. Acta Biomater. 2009 May; 5(4):983-92.
    View in: PubMed
    Score: 0.278
  9. The effect of glycosaminoglycan stabilization on tissue buckling in bioprosthetic heart valves. Biomaterials. 2008 Apr; 29(11):1645-53.
    View in: PubMed
    Score: 0.261
  10. Neomycin prevents enzyme-mediated glycosaminoglycan degradation in bioprosthetic heart valves. Biomaterials. 2007 Jun; 28(18):2861-8.
    View in: PubMed
    Score: 0.247
  11. Glycosaminoglycan-targeted fixation for improved bioprosthetic heart valve stabilization. Biomaterials. 2007 Jan; 28(3):496-503.
    View in: PubMed
    Score: 0.239
  12. Extracellular matrix degrading enzymes are active in porcine stentless aortic bioprosthetic heart valves. J Biomed Mater Res A. 2003 Sep 15; 66(4):755-63.
    View in: PubMed
    Score: 0.194
  13. Role of elastin in pathologic calcification of xenograft heart valves. J Biomed Mater Res A. 2003 Jul 01; 66(1):93-102.
    View in: PubMed
    Score: 0.191
  14. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study. J Heart Valve Dis. 2003 Mar; 12(2):226-34.
    View in: PubMed
    Score: 0.186
  15. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res. 1999 Jul; 46(1):44-50.
    View in: PubMed
    Score: 0.145
  16. Prevention of calcification of glutaraldehyde-crosslinked porcine aortic cusps by ethanol preincubation: mechanistic studies of protein structure and water-biomaterial relationships. J Biomed Mater Res. 1998 Jun 15; 40(4):577-85.
    View in: PubMed
    Score: 0.135
  17. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation. 1997 Jan 21; 95(2):479-88.
    View in: PubMed
    Score: 0.122
  18. Effects of collagen fiber orientation on the response of biologically derived soft tissue biomaterials to cyclic loading. J Biomed Mater Res A. 2007 Jan; 80(1):194-205.
    View in: PubMed
    Score: 0.061
  19. Tannic acid treatment enhances biostability and reduces calcification of glutaraldehyde fixed aortic wall. Biomaterials. 2005 Apr; 26(11):1237-45.
    View in: PubMed
    Score: 0.054
  20. Response of heterograft heart valve biomaterials to moderate cyclic loading. J Biomed Mater Res A. 2004 Jun 15; 69(4):658-69.
    View in: PubMed
    Score: 0.051
  21. Inhibition of cusp and aortic wall calcification in ethanol- and aluminum-treated bioprosthetic heart valves in sheep: background, mechanisms, and synergism. J Heart Valve Dis. 2003 Mar; 12(2):209-16; discussion 216.
    View in: PubMed
    Score: 0.047
  22. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003 Mar; 12(2):217-25.
    View in: PubMed
    Score: 0.047
  23. Aluminum chloride pretreatment of elastin inhibits elastolysis by matrix metalloproteinases and leads to inhibition of elastin-oriented calcification. Am J Pathol. 2001 Dec; 159(6):1981-6.
    View in: PubMed
    Score: 0.043
  24. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis. 2000 Jul; 9(4):561-6.
    View in: PubMed
    Score: 0.039
  25. Inhibition of aortic wall calcification in bioprosthetic heart valves by ethanol pretreatment: biochemical and biophysical mechanisms. J Biomed Mater Res. 1998 Oct; 42(1):30-7.
    View in: PubMed
    Score: 0.034
  26. On the biomechanical role of glycosaminoglycans in the aortic heart valve leaflet. Acta Biomater. 2013 Jan; 9(1):4653-60.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.